Advertisement
Screener

Nektar Therapeutics (NKTR) Increase (Decrease) in Other Operating Assets

2.8 / 5 stars · 68/120 Roast Me

Nektar Therapeutics Increase (Decrease) in Other Operating Assets

Nektar Therapeutics (NKTR) reported Increase (Decrease) in Other Operating Assets of $39.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-14

  • Nektar Therapeutics increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $40.83M.
  • Nektar Therapeutics increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$949.00K, a 115.93% decline year-over-year.
  • Nektar Therapeutics increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $9.86M, a 306.35% increase year-over-year.
  • Nektar Therapeutics increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $618.00K, a 82.73% decline year-over-year.
  • Nektar Therapeutics increase (decrease) in other operating assets for fiscal 2025 was $15.45M, a 268.98% increase from fiscal 2024.
  • Nektar Therapeutics increase (decrease) in other operating assets for fiscal 2024 was $4.19M.
  • Nektar Therapeutics increase (decrease) in other operating assets for fiscal 2023 was -$3.58M.
  • Nektar Therapeutics increase (decrease) in other operating assets for fiscal 2022 was -$6.91M, a 367.05% decline from fiscal 2021.
Period endIncrease (Decrease) in Other Operating Assets 3 monthIncrease (Decrease) in Other Operating Assets 6 monthIncrease (Decrease) in Other Operating Assets 9 monthIncrease (Decrease) in Other Operating Assets 9 month as first filedIncrease (Decrease) in Other Operating Assets 12 monthIncrease (Decrease) in Other Operating Assets 12 month as first filed
2026-06-30$40.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$39.88M
10-Q · filed 2026-08-14
$49.74M
derived: sum of 3 quarters · filed 2026-08-14
$50.36M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$949.00K
10-Q · filed 2026-05-08
$8.91M
derived: sum of 2 quarters · filed 2026-05-08
$9.53M
derived: sum of 3 quarters · filed 2026-05-08
$8.54M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$9.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$10.48M
derived: sum of 2 quarters · filed 2026-03-13
$9.49M
derived: sum of 3 quarters · filed 2026-08-14
$15.45M
10-K · filed 2026-03-13
2025-09-30$618.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$367.00K
derived: sum of 2 quarters · filed 2026-08-14
$5.59M
10-Q · filed 2025-11-07
$8.02M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$985.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$4.97M
10-Q · filed 2026-08-14
$7.40M
derived: sum of 3 quarters · filed 2026-08-14
$10.98M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$5.96M
10-Q · filed 2026-05-08
$8.38M
derived: sum of 2 quarters · filed 2026-05-08
$11.96M
derived: sum of 3 quarters · filed 2026-05-08
$9.17M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$2.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$6.00M
derived: sum of 2 quarters · filed 2026-03-13
$3.21M
derived: sum of 3 quarters · filed 2026-03-13
$4.19M
10-K · filed 2026-03-13
2024-09-30$3.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$785.00K
derived: sum of 2 quarters · filed 2025-11-07
$1.76M
10-Q · filed 2025-11-07
$2.63M
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30-$2.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$1.82M
10-Q · filed 2025-08-08
-$950.00K
derived: sum of 3 quarters · filed 2025-08-08
$2.50M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$976.00K
10-Q · filed 2025-05-09
$1.84M
derived: sum of 2 quarters · filed 2025-05-09
$5.29M
derived: sum of 3 quarters · filed 2025-05-09
$2.98M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$867.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
$4.32M
derived: sum of 2 quarters · filed 2025-03-14
$2.01M
derived: sum of 3 quarters · filed 2025-03-14
-$3.58M
10-K · filed 2025-03-14
2023-09-30$3.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$1.14M
derived: sum of 2 quarters · filed 2024-11-08
-$4.45M
10-Q · filed 2024-11-08
-$6.50M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30-$2.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$7.90M
10-Q · filed 2024-08-09
-$9.95M
derived: sum of 3 quarters · filed 2024-08-09
-$7.18M
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31-$5.59M
10-Q · filed 2024-05-10
-$7.64M
derived: sum of 2 quarters · filed 2024-05-10
-$4.87M
derived: sum of 3 quarters · filed 2024-05-10
-$9.63M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31-$2.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05
$721.00K
derived: sum of 2 quarters · filed 2024-03-05
-$4.04M
derived: sum of 3 quarters · filed 2024-03-05
-$6.91M
10-K · filed 2024-03-05
2022-09-30$2.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$2.00M
derived: sum of 2 quarters · filed 2023-11-08
-$4.86M
10-Q · filed 2023-11-08
-$1.46M
derived: sum of 4 quarters · filed 2024-03-05
2022-06-30-$4.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$7.63M
10-Q · filed 2023-08-09
-$4.23M
derived: sum of 3 quarters · filed 2024-03-05
$6.54M
derived: sum of 4 quarters · filed 2024-03-05
2022-03-31-$2.86M
10-Q · filed 2023-05-10
$536.00K
derived: sum of 2 quarters · filed 2024-03-05
$11.31M
derived: sum of 3 quarters · filed 2024-03-05
$5.91M
derived: sum of 4 quarters · filed 2024-03-05
2021-12-31$3.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05
$14.17M
derived: sum of 2 quarters · filed 2024-03-05
$8.77M
derived: sum of 3 quarters · filed 2024-03-05
$2.59M
10-K · filed 2024-03-05
$2.69M
10-K · filed 2022-03-01
2021-09-30$10.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
$5.37M
derived: sum of 2 quarters · filed 2022-11-04
-$814.00K
10-Q · filed 2022-11-04
-$10.91M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$5.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
-$11.59M
10-Q · filed 2022-08-05
-$21.68M
derived: sum of 3 quarters · filed 2023-02-28
-$43.31M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$6.18M
10-Q · filed 2022-05-06
-$16.28M
derived: sum of 2 quarters · filed 2023-02-28
-$37.91M
derived: sum of 3 quarters · filed 2023-02-28
-$9.63M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$10.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$31.73M
derived: sum of 2 quarters · filed 2023-02-28
-$3.44M
derived: sum of 3 quarters · filed 2023-02-28
-$4.51M
10-K · filed 2023-02-28
-$4.48M
10-K · filed 2021-02-26
2020-09-30-$21.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$6.66M
derived: sum of 2 quarters · filed 2021-11-05
$5.59M
10-Q · filed 2021-11-05
$22.52M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$28.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$27.21M
10-Q · filed 2021-08-06
$44.15M
derived: sum of 3 quarters · filed 2022-03-01
$41.84M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$1.07M
10-Q · filed 2021-05-07
$15.87M
derived: sum of 2 quarters · filed 2022-03-01
$13.56M
derived: sum of 3 quarters · filed 2022-03-01
$1.95M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$16.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$14.63M
derived: sum of 2 quarters · filed 2022-03-01
$3.02M
derived: sum of 3 quarters · filed 2022-03-01
-$1.19M
10-K · filed 2022-03-01
2019-09-30-$2.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$13.92M
derived: sum of 2 quarters · filed 2020-11-06
-$18.13M
10-Q · filed 2020-11-06
-$8.56M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30-$11.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$15.82M
10-Q · filed 2020-08-07
-$6.25M
derived: sum of 3 quarters · filed 2021-02-26
$1.55M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31-$4.21M
10-Q · filed 2020-05-08
$5.36M
derived: sum of 2 quarters · filed 2021-02-26
$13.16M
derived: sum of 3 quarters · filed 2021-02-26
$29.30M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$9.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$17.37M
derived: sum of 2 quarters · filed 2021-02-26
$33.51M
derived: sum of 3 quarters · filed 2021-02-26
$31.65M
10-K · filed 2021-02-26
2018-09-30$7.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$23.94M
derived: sum of 2 quarters · filed 2019-11-07
$22.09M
10-Q · filed 2019-11-07
$24.85M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$16.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$14.28M
10-Q · filed 2019-08-09
$17.05M
derived: sum of 3 quarters · filed 2020-02-28
$21.36M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31-$1.85M
10-Q · filed 2019-05-09
$911.00K
derived: sum of 2 quarters · filed 2020-02-28
$5.23M
derived: sum of 3 quarters · filed 2020-02-28
$5.08M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31$2.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$7.08M
derived: sum of 2 quarters · filed 2020-02-28
$6.93M
derived: sum of 3 quarters · filed 2020-02-28
$4.80M
10-K · filed 2020-02-28
2017-09-30$4.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$4.17M
derived: sum of 2 quarters · filed 2018-11-08
$2.04M
10-Q · filed 2018-11-08
$8.39M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30-$146.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$2.28M
10-Q · filed 2018-08-09
$4.07M
derived: sum of 3 quarters · filed 2019-03-01
$2.67M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$2.13M
10-Q · filed 2018-05-10
$4.22M
derived: sum of 2 quarters · filed 2019-03-01
$2.81M
derived: sum of 3 quarters · filed 2019-03-01
$2.47M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31$6.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$4.95M
derived: sum of 2 quarters · filed 2019-03-01
$4.61M
derived: sum of 3 quarters · filed 2019-03-01
$312.00K
10-K · filed 2019-03-01
2016-09-30-$1.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$1.75M
derived: sum of 2 quarters · filed 2017-11-08
-$6.04M
10-Q · filed 2017-11-08
-$1.37M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30-$343.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$4.64M
10-Q · filed 2017-08-09
$31.00K
derived: sum of 3 quarters · filed 2018-03-01
-$3.62M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31-$4.29M
10-Q · filed 2017-05-10
$374.00K
derived: sum of 2 quarters · filed 2018-03-01
-$3.28M
derived: sum of 3 quarters · filed 2018-03-01
-$660.00K
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$4.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$1.01M
derived: sum of 2 quarters · filed 2018-03-01
$3.63M
derived: sum of 3 quarters · filed 2018-03-01
$825.00K
10-K · filed 2018-03-01
2015-09-30-$3.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
-$1.03M
derived: sum of 2 quarters · filed 2016-11-04
-$3.84M
10-Q · filed 2016-11-04
$130.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$2.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$190.00K
10-Q · filed 2016-08-04
$3.78M
derived: sum of 3 quarters · filed 2017-03-01
$3.84M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$2.81M
10-Q · filed 2016-05-04
$1.16M
derived: sum of 2 quarters · filed 2017-03-01
$1.22M
derived: sum of 3 quarters · filed 2017-03-01
-$233.00K
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$3.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$4.03M
derived: sum of 2 quarters · filed 2017-03-01
$2.58M
derived: sum of 3 quarters · filed 2017-03-01
$3.29M
10-K · filed 2017-03-01
2014-09-30$59.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
-$1.40M
derived: sum of 2 quarters · filed 2015-11-06
-$679.00K
10-Q · filed 2015-11-06
-$285.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$1.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$738.00K
10-Q · filed 2015-08-06
-$344.00K
derived: sum of 3 quarters · filed 2016-02-29
-$1.65M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$718.00K
10-Q · filed 2015-05-01
$1.11M
derived: sum of 2 quarters · filed 2016-02-29
-$197.00K
derived: sum of 3 quarters · filed 2016-02-29
-$1.86M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$394.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$915.00K
derived: sum of 2 quarters · filed 2016-02-29
-$2.58M
derived: sum of 3 quarters · filed 2016-02-29
-$6.42M
10-K · filed 2016-02-29
2013-09-30-$1.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
-$2.97M
derived: sum of 2 quarters · filed 2014-11-07
-$6.82M
10-Q · filed 2014-11-07
-$2.25M
derived: sum of 4 quarters · filed 2015-02-26
2013-06-30-$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
-$5.51M
10-Q · filed 2014-08-01
-$946.00K
derived: sum of 3 quarters · filed 2015-02-26
-$3.36M
derived: sum of 4 quarters · filed 2015-02-26
2013-03-31-$3.84M
10-Q · filed 2014-05-08
$718.00K
derived: sum of 2 quarters · filed 2015-02-26
-$1.70M
derived: sum of 3 quarters · filed 2015-02-26
-$5.57M
derived: sum of 4 quarters · filed 2015-02-26
2012-12-31$4.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
$2.15M
derived: sum of 2 quarters · filed 2015-02-26
-$1.73M
derived: sum of 3 quarters · filed 2015-02-26
-$6.03M
10-K · filed 2015-02-26
2012-09-30-$2.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$6.29M
derived: sum of 2 quarters · filed 2013-11-07
-$10.59M
10-Q · filed 2013-11-07
$10.59M
10-Q · filed 2012-11-09
$3.42M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30-$3.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
-$8.18M
10-Q · filed 2013-08-09
$5.84M
derived: sum of 3 quarters · filed 2014-02-27
$1.90M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31-$4.30M
10-Q · filed 2013-05-09
$9.71M
derived: sum of 2 quarters · filed 2014-02-27
$5.77M
derived: sum of 3 quarters · filed 2014-02-27
$6.76M
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31$14.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
$10.08M
derived: sum of 2 quarters · filed 2014-02-27
$11.07M
derived: sum of 3 quarters · filed 2014-02-27
$12.27M
10-K · filed 2014-02-27
2011-09-30-$3.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
-$2.95M
derived: sum of 2 quarters · filed 2012-11-09
-$1.75M
10-Q · filed 2012-11-09
$1.75M
10-Q · filed 2011-11-04
-$2.33M
derived: sum of 4 quarters · filed 2013-03-01
2011-06-30$992.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$2.19M
10-Q · filed 2012-08-09
$1.61M
derived: sum of 3 quarters · filed 2013-03-01
$1.48M
derived: sum of 4 quarters · filed 2013-03-01
2011-03-31$1.20M
10-Q · filed 2012-05-04
$623.00K
derived: sum of 2 quarters · filed 2013-03-01
$486.00K
derived: sum of 3 quarters · filed 2013-03-01
-$261.00K
derived: sum of 4 quarters · filed 2013-03-01
2010-12-31-$576.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01
-$713.00K
derived: sum of 2 quarters · filed 2013-03-01
-$1.46M
derived: sum of 3 quarters · filed 2013-03-01
-$577.00K
10-K · filed 2013-03-01
2010-09-30-$137.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
-$884.00K
derived: sum of 2 quarters · filed 2011-11-04
-$1.00K
10-Q · filed 2011-11-04
2010-06-30-$747.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05
$136.00K
10-Q · filed 2011-08-05
2010-03-31$883.00K
10-Q · filed 2011-04-29
2009-12-31$200.00K
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Generate Biomedicines, Inc. (GENB)United States$2.052B
Biohaven Ltd. (BHVN)United States$1.990B-3.83
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89